How much funding has Contraline raised?

Contraline has raised $132.4M in total funding, most recently a Series B round.

Who are Contraline's investors?

Contraline's investors include BVF Partners, RA Capital Management, GV (Google Ventures), MBX Capital, Lumira Ventures, Rhia Ventures.

When was Contraline founded?

Contraline was founded in 2016.

Where is Contraline headquartered?

Contraline is headquartered in Charlottesville, Virginia, United States.

What industry is Contraline in?

Contraline operates in Biotech, Healthcare, Medical Devices.

How many employees does Contraline have?

Contraline has 11-50 employees.

Contraline

Inventing the future of male contraception.

Charlottesville, United States · Founded 2016 · $132.4M raised

Biotech

Healthcare

Medical Devices

Headquarters: Charlottesville, Virginia
Employees: 11–50
Founded: 2016
Business Model: B2C

Website: contraline.com
Total Funding: $132.4M
Last Round: $92.5M Series BJun 2026
Rounds: 6

About

Contraline is a biotechnology company inventing the future of male contraception. The company is developing two products: ADAM™, an injectable hydrogel implant designed to provide long-lasting, reversible barrier contraception for men without affecting sensation, and NES/T, a daily topical gel that suppresses sperm production reversibly. ADAM successfully completed its first-in-human clinical trial and Contraline holds an exclusive license for NES/T. Contraline's mission is to deliver highly effective, safe, and reversible male contraceptives that fit seamlessly into people's lives.

Summary

Contraline is a Biotech company based in Charlottesville, United States, founded in 2016. It has raised $132.4M in total across 6 rounds, most recently a $92.5M Series B round in Jun 2026. Investors include BVF Partners, RA Capital Management and GV (Google Ventures).

LinkedIn X (Twitter)